RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Vie di trasduzione e modifiche traduzionali e post-traduzionali nella protezione dall'apoptosi: disegno di nuove strategie terapeutiche antitumorali.
• 2 - Medulloblastoma: studio delle vie molecolari di sviluppo e progressione tumorale allo scopo di identificare approcci terapeutici innovativi
• 3 - ANALISI DEI MECCANISMI DI SOPRAVVIVENZA CELLULARE DI EUCARIOTI MEDIANTE STRATEGIE DI PROTEOMICA
• 4 - Apoptosi e terapia del cancro: caratterizzazione di nuovi meccanismi e nuove molecole modulatrici dell'apoptosi
• 5 - MECCANISMI REDOX DI SEGNALAZIONE CELLULARE COINVOLTI NELLA GENESI DI MALATTIE ASSOCIATE A STRESS OSSIDATIVO
• 6 - Estrogeni, recettori steroidei e carcinoma prostatico: modulazione dei meccanismi biomolecolari coinvolti nella progressione e metastatizzazione del tumore
• 7 - BERSAGLI MOLECOLARI PER NUOVE TERAPIE ANTINEOPLASTICHE ATTRAVERSO LO STUDIO DI PROTEINE-SEGNALE CELLULARI E VIRALI E DI INIBITORI SPECIFICI
• 8 - STRESS OSSIDATIVO, CANCRO E CRESCITA METASTATICA: RUOLO DELLA REGOLAZIONE REDOX
• 9 - Meccanismi molecolari di carcinogenesi: validazione di nuovi bersagli per la diagnosi e la terapia
• 10 - I membri della famiglia del TNF nella modulazione del differenziamento cellulare e dell'attività antitumorale

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • PATOLOGIA CLINICA
  • ONCOLOGIA MEDICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Campania

Bibliografia

Bismuto E, Martelli PL, De Maio A, Mita DG, Irace G, Casadio R (2002). Effect of molecular confinement on internal enzyme dynamics: frequency domain fluorometry and molecular dynamics simulation studies. Biopolymers, 67(2):85-95

Bismuto E, Irace G, Sirangelo I, Gratton E (1996). Pressure-induced perturbation of ANS-apomyoglobin complex: frequency domain fluorescence studies on native and acidic compact states. Protein Sci., 5(1):121-126

Bismuto E and Irace G (1994). Unfolding pathway of apomyoglobin. Simultaneous characterization of acidic conformational states by frequency domain fluorometry. J. Mol. Biol., 241(1):103-109

Bismuto E, Gratton E and Lamb DC (2001). Dynamics of ANS binding to tuna apomyoglobin measured with fluorescence correlation spectroscopy. Biophys. J., 81:3510-3521

Chen Y, Müller JD, Ruan Q. and Gratton E (2002). Molecular brightness characterization of EGFP in vivo by fluorescence fluctuation spectroscopy. Biophys. J. 82:133-144

Lindahl E, Hess B, van der Spoel D (2001). GROMACS 3.0: a package for molecular simulation and trajectory analysis. Journal of Molecular Modeling, 7(8):306-317

Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK and Olson AJ (1998). Automated Docking Using a Lamarckian Genetic Algorithm and and Empirical Binding Free Energy Function. J. Computational Chemistry, 19:1639-1662

Bismuto E, Martelli PL, Casadio R, Irace G (2000). Tryptophanyl fluorescence lifetime distribution of hyperthermophilic beta-glycosidase from molecular dynamics simulation: a comparison with the experimental data. Protein Sci., 9:1730-1742

Caraglia M, Budillon A, Tagliaferri PS and Abbruzzese A (2000). Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation.
Eur. J. Biochem., 267:3919-3936

Caraglia M, Marra M, Giuberti G, Budillon A, Di Gennaro E, Pepe S, De Lorenzo S, Vitale G, Improta S, Bianco AR, Venuta S, Tagliaferri P and Abbruzzese A (2003). EGF activates an inducible survival response from interferon-alpha-mediated apoptosis through the RAS -> ERK-1/2 pathway in epidermoid cancer cells. Cell Death Differ., 10:218-229

Caraglia M, Abbruzzese A, Leardi A, Pepe S, Budillon A, Baldassarre G, De Lorenzo S, Vitale G, Giuberti G, Fabbrocini A, Bianco AR and Tagliaferri P (1999). Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death and Differ., 6:773-781

Caraglia M, Marra M, Giuberti G, D’Alessandro AM, Tassoni P, Venuta S, Tagliaferri P and Abbruzzese A (2003). The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by Interferon-alpha and EGF in human cancer cells. J. Biochem., 133:757-765

Pierce C.B. and Speers W.C. Cancer Res., 48, 1996 1988

Beninati S., Cancer 1, 8,234, 1995

Beninati S. et al., Biochem. Biophys, Acta, 952, 325, 1988

Beninati S. et al., J.Bíochem. 115,675?682, 1994

Folk J.E., Annu. Rev. Biochem., 49,517?531, 1980

Piacentini M. et al., J. Biol. Chem., 263, 3, 790-794, 1988

Fesus L. et al., FEBS Lett. 245, 150, 1989

Russell D.H., Life Sci., 13, 1635-1647, 1973

Tabor C.W.and Tabor H., Ann. Rev. Biochem., 53, 749, 1980

Folk J.E. et al, J.Biol.Chem., 255, 3695?3700, 1980

Folk J.E. and J S. Finlayson, Adv. Prot. Chem. 31, 1, 1977

Beninati S. et al., Int. J. Cancer, 53, 792, 1993

Beninati S. et al., Life Chem . Rep. 10, 29?37, 1988

Martinet N. et al., Biochem, J., 271, 305?308, 1988

Seiler N. et al.., Int. J. Biochem. 13, 1205, 1981

Lentini A. et al., Melanoma Res., 8, 131-137, 1998

Beninati S. et al., FEBS Letters, 437, 34-38, 1998

Lentini A. and Beninati S. Minerva Biotecn. 14,2, 159-164, 2002

Lentini A. et al, Eur. J. Cancer 36, 1572-77, 2000

Lentini A. et al, Melanoma Res. 10,435-443, 2000
-Fjallskog ML, Ludvigsen E, Stridsberg M, Oberg K, Eriksson B, Janson ET. Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors. Med Oncol. 2003;20(1):59-67.
-Caraglia M, Abbruzzese A, Leardi A, Pepe S, Budillon A, Baldassare G,Selleri C, Lorenzo SD, Fabbrocini A, Giuberti G, Vitale G, Lupoli G, Bianco AR, Tagliaferri P. Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ. 1999;6(8):773-80.
-Budillon A, Tagliaferri P, Caraglia M, Torrisi MR, Normanno N, Iacobelli S, Palmieri G, Stoppelli MP, Frati L, Bianco AR. Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells.
Cancer Res. 1991;51(4):1294-9.
-Vernejoul F, Faure P, Benali N, Calise D, Tiraby G, Pradayrol L, Susini C, Buscail L. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. Cancer Res. 2002;62(21):6124-31.
-Battershill PE, Clissold SP. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs. 1989;38(5):658-702.
-Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S,Abbruzzese A, Lupoli G.Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin.
Clin Chem. 2002;48(9):1505-10.
-Vitale G, Fonderico F, Martignetti A, Caraglia M, Ciccarelli A, Nuzzo V,Abbruzzese A, Lupoli G. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer. 2001;84(12):1586-90.
-Lee MV, Fong EM, Singer FR, Guenette RS. Bisphosphonate treatment inhibits the growth of prostate cancer cells. Cancer Res. 2001;61(6):2602-8.
-Pilichowska M, Kimura N, Schindler M, Kobari M. Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.Endocr Pathol. 2001;12(2):147-55.
-Vitale G, Caraglia M, Ciccarelli A, Lupoli G, Abbruzzese A, Tagliaferri P,Lupoli G.Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer. 2001;91(9):1797-808.
-Vitale G, Tagliaferri P, Caraglia M, Rampone E, Ciccarelli A, Bianco AR, Abbruzzese A, Lupoli G. Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma. J Clin Endocrinol Metab. 2000;85(3):983-8.
-Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW. Bisphosphonates induce apoptosis in human breast cancer cell lines.Br J Cancer. 2000;82(8):1459-68.
-Lupoli G, Cascone E, Arlotta F, Vitale G, Celentano L, Salvatore M,
Lombardi G. Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide.Cancer. 1996;78(5):1114-8.
-Marzano LA, Porcelli A, Biondi B, Lupoli G, Delrio P, Lombardi G, Zarrilli L. Surgical management and follow-up of medullary thyroid carcinoma. J Surg Oncol. 1995;59(3):162-8.

Harpole DH et al.; Cancer, 1995, 76: 787-796.

Feld R et al.; J Clin Oncol, 1984, 2: 1352-1358.

Pisters KMW et al.; Proc Am Soc Clin Oncol, 1998, 17: 451a.

Martini N et al.; Surg Oncol Clin North Am, 1997, 6: 769-791.

Feld R et al.; J natl Cancer Inst, 1993; 85: 299-306.

Roth JA et al.; J Natl Cancer Inst, 1994, 86: 673-680.

Rosell R et al.; N Engl J Med, 1994, 330:153-158.

Zochbauer-Muller S et al.; Annu Rev Physiol, 2002, 64: 681-708.

MacLachlan TK et al.; Eukariotic Gene Expr, 1995, 5:127-156.

Sherr CJ; Science, 1996, 274: 1672-1677.

Serrano M et al.; Cell, 1996, 85: 27-37.

Sekido Y et al.; Biochem Biophys Acta, 1998, 1378: F21-59.

Ewen ME; Cancer Metastasis Rev, 1994, 13:45-66.

Xu HJ et al.; J Natl Cancer Inst, 1994, 86: 695-699.

Dosaka-Akita H et al.; Cancer, 1997, 79: 1329-1337.

Shimizu E et al.; Oncogene, 1994, 9: 2441-2448.

Baldi A et al.; Clin Cancer Res, 1997, 3: 1691-1697.

Parole Chiave

GENOMICA; PROTEOMICA; ANALOGHI DELLA SOMATOSTATINA; RAS; MICROSCOPIA FLIM; PROTEINE REGOLATRICI DEL CICLO CELLULARE; INIBITORI DELLE FARNESIL TRANSFERASI; COMPARTIMENTALIZZAZIONE INTRACELLULARE; APOPTOSI